BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9198207)

  • 1. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; from homocysteine to hyperhomocysteinemia].
    Boers GH
    Ned Tijdschr Geneeskd; 2001 May; 145(20):956-8. PubMed ID: 11396261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Boers GH
    Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia: a new independent vascular risk factor?].
    Cafagna D; Ponte E
    Minerva Cardioangiol; 1997; 45(1-2):49-55. PubMed ID: 9213816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment.
    Boers G
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S127-30. PubMed ID: 9587040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
    de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
    Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and venous thrombosis.
    Quéré I; Gris JC; Dauzat M
    Semin Vasc Med; 2005 May; 5(2):183-9. PubMed ID: 16047270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and thrombosis.
    Guba SC; Fonseca V; Fink LM
    Semin Thromb Hemost; 1999; 25(3):291-309. PubMed ID: 10443960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; Den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2003 Jan; 11(1):23-9. PubMed ID: 12529702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and venous thrombosis.
    Gatt A; Makris M
    Semin Hematol; 2007 Apr; 44(2):70-6. PubMed ID: 17433898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.